Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.
about
Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Healthcare utilization and cos ...... with chronic myeloid leukemia.
@en
type
label
Healthcare utilization and cos ...... with chronic myeloid leukemia.
@en
prefLabel
Healthcare utilization and cos ...... with chronic myeloid leukemia.
@en
P2093
P2860
P1433
P1476
Healthcare utilization and cos ...... with chronic myeloid leukemia
@en
P2093
Ashutosh Pathak
Boxiong Tang
Gisoo Barnes
Patricia Kropf
P2860
P304
P356
10.3109/10428194.2015.1088654
P577
2015-11-20T00:00:00Z